[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Blood Cancer United\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":85},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,65],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100624773","expressive-writing-program-among-young-adults-with-blood-cancer-100624773",false,"NCT07413991","Expressive Writing Program Among Young Adults With Blood Cancer","An Expressive Writing Program to Support Emotional Wellness Among Young Adults With Hematologic Malignancy","Inclusion Criteria:\n\n* Patient with a hematologic malignancy diagnosis in treatment or after treatment is completed, who is currently between the ages of 18 and 39 (young adult), or the informal caregiver of a young adult blood cancer patient\n* Located within the U.S., Canada, or U.S. territories\n* Able to read and write in English\n\nExclusion Criteria:\n\n* Located outside of the U.S., Canada, or its territories\n* Participant is a minor aged 17 years or below","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this study is to learn more about an expressive writing workshop among people with blood cancer. The main question it aims to answer is whether and how an expressive writing workshop can impact mental wellness.\n\nParticipants will\n\n* Take part in an online expressive writing workshop for four weeks\n* Take three surveys at different times over 12 weeks Researchers will compare changes in mental wellness reported by the participants of the workshop to those who will wait four weeks to start the workshop. After four weeks, the participants who are waiting will start their workshop.",[26],"Hematologic Malignancy",[28],"expressive writing","RECRUITING","2026-05-01",{"date":32,"type":33},"2026-05-07","ACTUAL",{"date":35,"type":33},"2026-02-01",{"date":37,"type":20},"2026-09-30",{"name":39,"class":40},"Blood Cancer United","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":48,"targetDuration":50,"studyType":51,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":41},"100606266","the-impact-of-car-t-cell-therapy-on-fertility-a-patient-survey-100606266","NCT07173322","The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey","* any cancer patient\n* at least 18 years of age\n* with a history of receiving CAR-T Cell treatment.\n\nless than 18 years old.\n\n\\-",{"count":49,"type":20},200,"1 Year","OBSERVATIONAL","As there is limited knowledge regarding the impact of CAR-T Cell therapy on fertility, LLS has designed a Patient Survey to learn more about the impact on fertility in patients who have received\u002Fare receiving CAR-T Cell treatment. The insights gained from this survey will inform future treatment protocols and fertility preservation strategies.",[54],"Cancer",[54,56],"CAR Tcell treatment","2025-09-07",{"date":59,"type":33},"2025-09-15",{"date":61,"type":33},"2025-02-09",{"date":63,"type":20},"2026-02-09",{"name":39,"class":40},{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":16,"minAge":71,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":74,"conditions":75,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":41},"100424392","the-leukemia-and-lymphoma-society-lls-national-research-registry-100424392","NCT04806295","The Leukemia and Lymphoma Society (LLS) National Research Registry","Inclusion Criteria:\n\nPeople with blood cancer, before, during, and after blood cancer treatments.\n\nExclusion Criteria:\n\nPeople unable or unwilling to sign informed consent.","21 Years",{"count":73,"type":20},1000,"The Leukemia and Lymphoma Society (LLS) has built a National Research Registry to evaluate real world experiences and medical outcomes for people with blood cancer, before, during, and after blood cancer treatments.",[76],"Blood Cancer","2022-04-05",{"date":79,"type":33},"2022-04-07",{"date":81,"type":33},"2017-07-24",{"date":83,"type":20},"2027-07-23",{"name":39,"class":40},""]